J. Nick Riehle, Chief Financial Officer at Chelsea Therapeutics International, Ltd. (CHTP), bought 2,500 shares at $2.20 ($6K) on 2009-12-21, disclosed to the SEC on 2009-12-22.
Open-market purchase of $6k CHTP by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CHTP | BUY | 2008-09-25 | $6K | — | Filing → |